Shane Storey
Stock Analyst at Canaccord Genuity
(3.20)
# 2,523
Out of 5,014 analysts
351
Total ratings
46.9%
Success rate
2.7%
Average return
Main Sectors:
Stocks Rated by Shane Storey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: RMD ResMed Inc. | Reiterated: Buy | $40.00 | $31.46 | +27.15% | 22 | Sep 28, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Reiterated: Buy | $30.25 → $31.50 | $15.36 | +105.14% | 58 | Sep 21, 2026 | |
| ASX: CSL CSL Limited | Reiterated: Hold | $106.31 → $185.00 | $178.63 | +3.57% | 29 | Sep 4, 2026 | |
| ASX: ACW Actinogen Medical Limited | Reiterated: Buy | $0.08 | $0.06 | +45.45% | 6 | Sep 3, 2026 | |
| ASX: SOM SomnoMed Limited | Reiterated: Buy | $1.00 → $0.76 | $0.30 | +153.33% | 23 | Aug 31, 2026 | |
| ASX: PNV PolyNovo Limited | Downgraded: Hold | $1.58 → $0.95 | $0.91 | +4.97% | 17 | Aug 27, 2026 | |
| NZE: FPH Fisher & Paykel Healthcare Corporation Limited | Reiterated: Buy | $46.48 → $45.24 | $46.45 | -2.59% | 16 | May 27, 2026 | |
| ASX: ARX Aroa Biosurgery Limited | Reiterated: Buy | $1.16 → $1.35 | $0.50 | +172.73% | 28 | May 3, 2026 | |
| ASX: COH Cochlear Limited | Reiterated: Buy | $295.00 → $120.00 | $130.66 | -8.16% | 19 | Apr 29, 2026 | |
| ASX: MVF Monash IVF Group Limited | Reiterated: Hold | $0.69 → $0.86 | $0.74 | +17.01% | 20 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.33 → $1.26 | $0.77 | +63.64% | 2 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.00 → $2.57 | $2.15 | +19.53% | 12 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.43 → $5.55 | $2.87 | +93.38% | 21 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.85 → $2.40 | $2.77 | -13.20% | 3 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.07 → $0.06 | $0.00 | +1,400.00% | 22 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $350.00 | $161.27 | +117.03% | 5 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.85 → $0.80 | $0.23 | +247.83% | 4 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $37.00 | $54.63 | -32.27% | 11 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32.84 | $8.35 | n/a | 3 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.00 → $2.81 | $0.28 | n/a | 4 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.20 | $0.03 | n/a | 2 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.00 | $2.53 | n/a | 3 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26.50 | $20.03 | n/a | 1 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8.50 | $2.09 | n/a | 7 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.00 | $0.01 | n/a | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5.95 → $7.40 | $2.83 | n/a | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.71 → $0.55 | $0.45 | n/a | 3 | Feb 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $0.17 → $0.06 | $0.82 | n/a | 2 | Sep 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.50 → $0.55 | $0.10 | n/a | 3 | Aug 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.75 | $0.01 | n/a | 1 | Jun 1, 2022 |
ResMed Inc.
Sep 28, 2026
Reiterated: Buy
Price Target: $40.00
Current: $31.46
Upside: +27.15%
Telix Pharmaceuticals Limited
Sep 21, 2026
Reiterated: Buy
Price Target: $30.25 → $31.50
Current: $15.36
Upside: +105.14%
CSL Limited
Sep 4, 2026
Reiterated: Hold
Price Target: $106.31 → $185.00
Current: $178.63
Upside: +3.57%
Actinogen Medical Limited
Sep 3, 2026
Reiterated: Buy
Price Target: $0.08
Current: $0.06
Upside: +45.45%
SomnoMed Limited
Aug 31, 2026
Reiterated: Buy
Price Target: $1.00 → $0.76
Current: $0.30
Upside: +153.33%
PolyNovo Limited
Aug 27, 2026
Downgraded: Hold
Price Target: $1.58 → $0.95
Current: $0.91
Upside: +4.97%
Fisher & Paykel Healthcare Corporation Limited
May 27, 2026
Reiterated: Buy
Price Target: $46.48 → $45.24
Current: $46.45
Upside: -2.59%
Aroa Biosurgery Limited
May 3, 2026
Reiterated: Buy
Price Target: $1.16 → $1.35
Current: $0.50
Upside: +172.73%
Cochlear Limited
Apr 29, 2026
Reiterated: Buy
Price Target: $295.00 → $120.00
Current: $130.66
Upside: -8.16%
Monash IVF Group Limited
Apr 29, 2026
Reiterated: Hold
Price Target: $0.69 → $0.86
Current: $0.74
Upside: +17.01%
Apr 20, 2026
Reiterated: Buy
Price Target: $1.33 → $1.26
Current: $0.77
Upside: +63.64%
Mar 4, 2026
Reiterated: Buy
Price Target: $3.00 → $2.57
Current: $2.15
Upside: +19.53%
Mar 4, 2026
Reiterated: Buy
Price Target: $5.43 → $5.55
Current: $2.87
Upside: +93.38%
Feb 17, 2026
Downgraded: Hold
Price Target: $3.85 → $2.40
Current: $2.77
Upside: -13.20%
Feb 2, 2026
Reiterated: Buy
Price Target: $0.07 → $0.06
Current: $0.00
Upside: +1,400.00%
Nov 18, 2025
Reiterated: Buy
Price Target: $350.00
Current: $161.27
Upside: +117.03%
Nov 7, 2025
Reiterated: Buy
Price Target: $0.85 → $0.80
Current: $0.23
Upside: +247.83%
Oct 3, 2025
Reiterated: Hold
Price Target: $37.00
Current: $54.63
Upside: -32.27%
Sep 24, 2025
Reiterated: Buy
Price Target: $32.84
Current: $8.35
Upside: n/a
Sep 11, 2025
Reiterated: Buy
Price Target: $3.00 → $2.81
Current: $0.28
Upside: n/a
Sep 10, 2025
Reiterated: Buy
Price Target: $1.20
Current: $0.03
Upside: n/a
Sep 2, 2025
Reiterated: Buy
Price Target: $3.00
Current: $2.53
Upside: n/a
Aug 28, 2025
Reiterated: Buy
Price Target: $26.50
Current: $20.03
Upside: n/a
Aug 8, 2025
Reiterated: Buy
Price Target: $8.50
Current: $2.09
Upside: n/a
Mar 24, 2025
Reiterated: Hold
Price Target: $1.00
Current: $0.01
Upside: n/a
Feb 27, 2025
Downgraded: Hold
Price Target: $5.95 → $7.40
Current: $2.83
Upside: n/a
Feb 21, 2023
Reiterated: Hold
Price Target: $0.71 → $0.55
Current: $0.45
Upside: n/a
Sep 2, 2022
Downgraded: Hold
Price Target: $0.17 → $0.06
Current: $0.82
Upside: n/a
Aug 29, 2022
Reiterated: Hold
Price Target: $0.50 → $0.55
Current: $0.10
Upside: n/a
Jun 1, 2022
Reiterated: Buy
Price Target: $0.75
Current: $0.01
Upside: n/a